Lessee, Operating Lease, Liability, to be Paid of Dianthus Therapeutics, Inc. /DE/ from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Dianthus Therapeutics, Inc. /DE/ Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $1,627,000, a 396% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,627,000 +$1,299,000 +396% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,700,000 +$1,266,000 +292% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,794,000 +$1,258,000 +235% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,922,000 +$1,283,000 +201% 31 Dec 2024 10-K 11 Mar 2025 2024 FY
Q3 2024 $328,000 -$413,000 -56% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $434,000 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $536,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $639,000 -$265,000 -29% 31 Dec 2023 10-K 21 Mar 2024 2023 FY
Q3 2023 $741,000 -$40,829,000 -98% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q4 2022 $904,000 31 Dec 2022 8-K 21 Dec 2023
Q3 2022 $41,570,000 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $43,244,000 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.